Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
'Not an adjunct to the pharma industry': Medical device representatives seek separate regulatory authority
Close to a dozen medical device and civil society organisations, among others, have sought a National Medical Devices Regulatory Authority, with the autonomy of telecom body TRAI or insurance's IRDAI, and regulatory oversight of food authority…
Basel's world-beating pharma hub fights for place in new global order
Few cities in the world have an identity so tightly bound to an industry as Basel and pharmaceuticals. Roche and Novartis, two of the world's biggest drugmakers, loom large over the city. Walk across any bridge in the city, and you can see the…
Swiss pharma companies flock to North Carolina
Mountains, waterfalls, Atlantic beaches – North Carolina's natural beauty is captivating. But that's not why Swiss companies are moving to the state. It is rather thanks to an active investment promotion policy. This policy has become all…
BridgeBio Pharma: Q2 Earnings Snapshot
PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Monday reported a loss of $152.2 million in its second quarter. On a per-share basis, the Palo Alto, California-based company said it had a loss of 78…
BridgeBio Pharma, Inc. (BBIO) Q2 2026 Earnings Call Transcript
BridgeBio Pharma, Inc. (BBIO) Q2 2026 Earnings Call August 10, 2026 4:30 PM EDT Chinmay Shukla - Senior Vice President of Strategic Finance Neil Kumar - Co-Founder, CEO & Director Matthew Outten - Chief Commercial Officer Thomas Trimarchi - CFO &…
Gujarat pharma firm partners held for illegal sale of codeine cough syrup
4 min read Ahmedabad Make us preferred source on Google The Special Operations Group (SOG) of the Ahmedabad City Police has arrested two partners of Ahmedabad-based wholesale pharmaceuticals company on the charge of selling Codeine-based cough…
'Suggestions not accepted': Bill to overhaul drugs law faces opposition from pharma, medical device sector
5 min read New Delhi Make us preferred source on Google A Bill to overhaul the Drugs and Cosmetics Act, 1940, currently being circulated to stakeholder ministries, is facing fierce opposition from the country's nascent medical device sector.
BridgeBio Pharma Q2 Earnings Call Highlights
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions BridgeBio Pharma NASDAQ: BBIO reported continued growth for its ATTR cardiomyopathy treatment Attruby in the second quarter of 2026, while advancing three late-stage…
BridgeBio Pharma (NASDAQ:BBIO) Announces Earnings Results
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.78) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.58) by ($0.20), FiscalAI…
Q3 EPS Estimates for Spyglass Pharma Decreased by Analyst
Spyglass Pharma, Inc. (NASDAQ:SGP - Free Report) - Equities research analysts at HC Wainwright cut their Q3 2026 earnings estimates for shares of Spyglass Pharma in a research report issued to clients and investors on Friday, August 7th. HC…
Innate Pharma (NASDAQ:IPHA) Stock Rating Upgraded by Leerink Partners
Innate Pharma (NASDAQ:IPHA - Get Free Report) was upgraded by analysts at Leerink Partners from a 'market perform' rating to an 'outperform' rating in a report issued on Tuesday, Marketbeat Ratings reports. The brokerage presently has a $4.00 price…
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Given Average Rating of 'Moderate Buy' by Analysts
Shares of Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) have earned a consensus rating of 'Moderate Buy' from the six research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has…
Morgan Stanley Has Lowered Expectations for BridgeBio Pharma (NASDAQ:BBIO) Stock Price
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price dropped by investment analysts at Morgan Stanley from $98.00 to $97.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an 'overweight'…
Piper Sandler Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price hoisted by investment analysts at Piper Sandler from $111.00 to $115.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has an 'overweight' rating…
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, TD Cowen Analyst Says
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price objective hoisted by investment analysts at TD Cowen from $95.00 to $110.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a 'buy' rating on…
Receive a Daily briefing on Pharma Industry News
Get Started